Highmark Expands Coverage for Virtual Reality Therapy
FDA-authorized RelieVRx is now a covered treatment for Highmark's commercial members experiencing chronic low back pain (CLBP)
AppliedVR, a leader in immersive therapeutic solutions, has some exciting news. Highmark, a prominent health insurance provider, has officially included the innovative treatment known as RelieVRx in its coverage. This device is specifically designed to assist individuals suffering from chronic low back pain, making it a vital tool for managing their health. With this decision, over four million Highmark members can now access a therapeutic method that utilizes the power of virtual reality (VR) for effective pain management.
What is RelieVRx?
RelieVRx offers a distinctive and fully immersive virtual reality experience that empowers users to develop effective pain management skills. As a non-pharmacologic treatment option, this device serves as a cost-effective alternative to traditional therapies. Clinical studies have demonstrated that it significantly alleviates pain intensity and interference, catering to a wide range of users across different demographics.
Program Details and Usability
The RelieVRx program features a structured regimen of 56 sessions. Patients participate in daily VR sessions that address the biological, psychological, and social dimensions of their pain experience. Designed for self-administration, patients can easily use the device in the comfort of their own homes. Clinical trials have consistently reported high usability ratings for RelieVRx, confirming its effectiveness and user-friendly design.
Clinical Evidence and Accessibility
Highmark’s decision to include RelieVRx in its coverage was based on a comprehensive review of clinical studies conducted by AppliedVR. One significant study, which involved over 1,000 participants, showed that the device has a substantial impact on pain reduction. Patients diagnosed with moderate to severe chronic low back pain can now easily obtain prescriptions for this treatment from their healthcare providers without needing prior authorization.
Statements from Leadership
In a recent statement, Matt Fickie, Senior Medical Director for Highmark, highlighted the crucial role of technology in enhancing health outcomes while managing costs. He remarked, "RelieVRx from AppliedVR provides our members suffering from chronic low back pain a scientifically backed, in-home immersive non-opioid treatment option." This insight underscores the collaboration between health insurance providers and innovative therapeutic solutions.
The Economic and Social Impact of Chronic Pain
Chronic pain represents a significant challenge in the United States, with considerable financial repercussions. It is estimated to cost the economy around $635 billion each year, contributing to the growing opioid crisis. Additionally, approximately 72 million Americans are reported to experience chronic low back pain, which is recognized as a leading cause of disability. Addressing this issue is essential for improving public health and economic stability.
Vision for Future Treatment Options
Matthew Stoudt, Co-founder and CEO of AppliedVR, expressed appreciation to Highmark for their progressive approach. He emphasized the importance of noninvasive, drug-free options that empower individuals to manage their pain effectively. By combining clinical evidence with immersive therapy, AppliedVR aims to transform how pain is perceived and treated.
Expansion and Momentum for AppliedVR
While Highmark is the first commercial health insurance provider to cover RelieVRx, AppliedVR has recently gained considerable traction with other health plans as well. Notable developments include receiving a unique code and pricing determination from the Centers for Medicare and Medicaid Services, establishing AppliedVR as a leader in its field. Additionally, the implementation of RelieVRx in several Veterans Affairs sites reflects the growing acceptance and recognition of this therapy across various healthcare systems.
Conclusion
As the healthcare landscape evolves, the integration of innovative solutions like RelieVRx establishes a new benchmark for pain management. The partnership between Highmark and AppliedVR not only enhances patient care but also fosters a deeper understanding of alternative treatments for managing chronic conditions. Through this collaboration, there is renewed hope for many individuals suffering from chronic low back pain.
Frequently Asked Questions
What is RelieVRx?
RelieVRx is a virtual reality device designed to provide immersive therapy for individuals suffering from chronic low back pain.
Who can access RelieVRx through Highmark?
Eligible commercial members aged 18 and older who are diagnosed with moderate to severe chronic low back pain can access the device with a prescription.
How does the RelieVRx program work?
The program consists of a 56-session regimen that patients complete primarily at home, utilizing daily VR sessions to manage their pain.
Is there any cost associated with accessing RelieVRx through Highmark?
Highmark's coverage enables eligible patients to obtain the device without prior authorization, thereby making it more accessible.
How has the response been to RelieVRx?
Clinical studies indicate high usability ratings for RelieVRx, showcasing positive feedback from participants regarding its effectiveness in pain management.
